Literature DB >> 34483772

Perspectives in Psychopharmacology.

.   

Abstract

Entities:  

Year:  2021        PMID： 34483772      PMCID： PMC8412152          DOI： 10.1176/appi.focus.19106

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN： 1541-4094


× No keyword cloud information.
  35 in total

1.  A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression.

Authors:  Pim Cuijpers; Hisashi Noma; Eirini Karyotaki; Christiaan H Vinkers; Andrea Cipriani; Toshi A Furukawa
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

2.  Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.

Authors:  Mark L Wolraich; Joseph F Hagan; Carla Allan; Eugenia Chan; Dale Davison; Marian Earls; Steven W Evans; Susan K Flinn; Tanya Froehlich; Jennifer Frost; Joseph R Holbrook; Christoph Ulrich Lehmann; Herschel Robert Lessin; Kymika Okechukwu; Karen L Pierce; Jonathan D Winner; William Zurhellen
Journal:  Pediatrics       Date:  2019-10       Impact factor: 7.124

3.  Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review.

Authors:  Parnian Pardis; Gary Remington; Roshni Panda; Milan Lemez; Ofer Agid
Journal:  J Psychopharmacol       Date:  2019-07-26       Impact factor: 4.153

Review 4.  Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone.

Authors:  Filippo Corponi; Chiara Fabbri; Istvan Bitter; Stuart Montgomery; Eduard Vieta; Siegfried Kasper; Stefano Pallanti; Alessandro Serretti
Journal:  Eur Neuropsychopharmacol       Date:  2019-06-27       Impact factor: 4.600

5.  The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials.

Authors:  Davy Vancampfort; Joseph Firth; Christoph U Correll; Marco Solmi; Dan Siskind; Marc De Hert; Rebekah Carney; Ai Koyanagi; André F Carvalho; Fiona Gaughran; Brendon Stubbs
Journal:  World Psychiatry       Date:  2019-02       Impact factor: 49.548

Review 6.  The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women.

Authors:  Anita H Clayton; Irwin Goldstein; Noel N Kim; Stanley E Althof; Stephanie S Faubion; Brooke M Faught; Sharon J Parish; James A Simon; Linda Vignozzi; Kristin Christiansen; Susan R Davis; Murray A Freedman; Sheryl A Kingsberg; Paraskevi-Sofia Kirana; Lisa Larkin; Marita McCabe; Richard Sadovsky
Journal:  Mayo Clin Proc       Date:  2018-03-12       Impact factor: 7.616

7.  Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression.

Authors:  Brent P Forester; Sagar V Parikh; Sara Weisenbach; Olusola Ajilore; Ipsit Vahia; Anthony J Rothschild; Michael E Thase; Boadie W Dunlop; Charles DeBattista; Charles R Conway; Richard C Shelton; Matthew Macaluso; James Li; Paul Traxler; Jennifer Logan; Lisa Brown; Bryan Dechairo; John F Greden
Journal:  Am J Geriatr Psychiatry       Date:  2020-05-19       Impact factor: 4.105

8.  Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.

Authors:  Toshi A Furukawa; Andrea Cipriani; Philip J Cowen; Stefan Leucht; Matthias Egger; Georgia Salanti
Journal:  Lancet Psychiatry       Date:  2019-06-06       Impact factor: 27.083

9.  Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.

Authors:  Sheryl A Kingsberg; Anita H Clayton; David Portman; Laura A Williams; Julie Krop; Robert Jordan; Johna Lucas; James A Simon
Journal:  Obstet Gynecol       Date:  2019-11       Impact factor: 7.661

10.  Comparative effects of varenicline or combination nicotine replacement therapy versus patch monotherapy on candidate mediators of early abstinence in a smoking cessation attempt.

Authors:  Nayoung Kim; Danielle E McCarthy; Megan E Piper; Timothy B Baker
Journal:  Addiction       Date:  2020-10-01       Impact factor: 6.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.